Medical News

RSS

Interleukin Genetics second quarter total revenue increases to $0.8 million

Interleukin Genetics, Inc. today announced financial and operational results for the second quarter ended June 30, 2011.

12 Aug 2011

USPTO grants Bion new patent for removal of phosphorus

Bion Environmental Technologies, Inc. announced today that it has been notified by the United States Patent and Trademark Office that the patent application entitled "Micro-Electron Acceptor Phosphorus Accumulating Organisms" has been granted.

12 Aug 2011

Echo net loss for first half 2011 increases to $6.5 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced results for the period ended June 30, 2011.

12 Aug 2011

Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed a pre-IND (Investigational New Drug) meeting with the FDA on August 10 to discuss the development plan for ADXS-PSA, a construct for the treatment of prostate cancer.

12 Aug 2011

Bovie Medical second quarter revenues increase 16% to $6.8 million

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the second quarter and six months ended June 30, 2011.

12 Aug 2011

ShangPharma approves share repurchase program

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its Board of Directors has approved a share repurchase program.

12 Aug 2011

First Edition: August 12, 2011

Kaiser Health News' Mary Agnes Carey and Politico Pro's David Nather talk to Jackie Judd about the now complete "super committee" and what it may mean for Medicare and Medicaid.

12 Aug 2011

Soligenix second quarter revenues decrease to $406,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2011.

12 Aug 2011

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

12 Aug 2011

Medical Facilities second quarter revenue increases to $54.3 million

Medical Facilities Corporation, today reported its financial results for the three-month and six-month periods ended June 30, 2011.

12 Aug 2011

Tanning beds may spur addictive neurological reward and reinforcement trigger

People who frequently use tanning beds may be spurred by an addictive neurological reward-and-reinforcement trigger, researchers at UT Southwestern Medical Center have found in a pilot study.

12 Aug 2011

Sinovac second quarter sales increase 52.5% to $15.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2011.

12 Aug 2011

Study confirms ability of Tru-D device to decontaminate surfaces in patient rooms

In an original article coauthored by John M. Boyce, MD; Nancy L. Havill, MT; and Brent A. Moore, PhD, "Terminal Decontamination of Patient Rooms Using an Automated Mobile UV Light Unit", the research team from the Hospital of Saint Raphael and the Yale University School of Medicine ". . . demonstrated that an automated, portable UV light device significantly reduced aerobic colony counts on high-touch surfaces in patient rooms.

12 Aug 2011

Nutrastar second quarter revenue increases 40.8% to $7.68 million

Nutrastar International Inc., a leading producer and supplier of premium branded Traditional Chinese Medicine consumer products, today announced record financial results for the three and six months ended June 30, 2011.

12 Aug 2011

Mylan introduces generic version of Uroxatral for benign prostatic hyperplasia

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg.

12 Aug 2011

Conmed second quarter net revenue increases 13.0% to $16.7 million

Conmed Healthcare Management, Inc. today announced financial results for the three- and six-month periods ended June 30, 2011.

12 Aug 2011

Biomarkers may transform diagnosis of kidney disease

Acute kidney injury (AKI) is a common - but preventable -- complication after surgery that can lead to other complications or even death. The use and development of biomarkers will help physicians diagnose and treat acute kidney injury.

12 Aug 2011

Renewed focus on veterans' coverage gap

From the critical moments after she suffered a gunshot wound to the head in January to her triumphant return to Congress last week for a vote on the debt-limit deal, Rep. Gabrielle Giffords owes her recovery in no small part to veterans with similar injuries.

12 Aug 2011

Researchers explain why vertebrate intestines are so predictably loopy

Between conception and birth, the human gut grows more than two meters long, looping and coiling within the tiny abdomen. Within a given species, the developing vertebrate gut always loops into the same formation-however, until now, it has not been clear why.

12 Aug 2011

Amorfix provides update on cancer therapeutic antibody programs

Amorfix Life Sciences Ltd., a product development company focused on diagnostics and therapeutics for misfolded protein diseases, provides an update on its cancer therapeutic antibody programs.

12 Aug 2011